Health and Fitness Health and Fitness
Mon, November 14, 2011
[ Mon, Nov 14th 2011 ] - Market Wire
30 AM Eastern Time
Sun, November 13, 2011
Sat, November 12, 2011
Fri, November 11, 2011
Thu, November 10, 2011
Wed, November 9, 2011
Tue, November 8, 2011
Mon, November 7, 2011
[ Mon, Nov 07th 2011 ] - Market Wire
30 a.m. ET
Sun, November 6, 2011
Sat, November 5, 2011
Fri, November 4, 2011
Thu, November 3, 2011
Wed, November 2, 2011
Tue, November 1, 2011
Mon, October 31, 2011
Sat, October 29, 2011
Fri, October 28, 2011

PDL BioPharma to Present at Lazard Capital Markets 8th Annual Healthcare Conference


//health-fitness.news-articles.net/content/2011/ .. al-markets-8th-annual-healthcare-conference.html
Published in Health and Fitness on Tuesday, November 8th 2011 at 4:25 GMT by Market Wire   Print publication without navigation


PDL BioPharma to Present at Lazard Capital Markets 8th Annual Healthcare... -- INCLINE VILLAGE, Nev., Nov. 8, 2011 /PRNewswire/ --

PDL BioPharma to Present at Lazard Capital Markets 8th Annual Healthcare Conference

[ ]

INCLINE VILLAGE, Nev., Nov. 8, 2011/PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: [ PDLI ]) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Lazard Capital Markets 8th Annual Healthcare Conference next week in New York City.  The presentation will begin at 10 a.m. EST on Tuesday, November 15, 2011.

(Logo:  [ http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ])

To access the live and subsequently archived webcasts of the presentations, go to the Company's website at [ http://www.pdl.com ] and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. The archived webcast will be available for seven days following each presentation.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. For more information, please visit [ www.pdl.com ].

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

SOURCE PDL BioPharma, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.pdl.com ]


Publication Contributing Sources